Nyumbani › Scleroderma › New York › New York City
Majaribio ya kliniki ya Scleroderma katika New York City, NY
Masomo 11 ya Scleroderma yanatafuta washiriki katika vituo vya New York City na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
InaajiriHatua 3
- Hospital for Special Surgery, New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center-New York Presbyterian Hospital, New York
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
InaajiriHatua 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
InaajiriHatua 1
- Icahn School of Medicine at Mount Sinai, New York
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
InaajiriHatua 2/3
- GSK Investigational Site, New York
- GSK Investigational Site, New York
Platform Clinical Study for Conquering Scleroderma
InaajiriHatua 2
- Hospital for Special Surgery, New York
- Columbia University Medical Center, New York
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
InaajiriHatua 2/3
- Columbia University Irving Medical Center, New York
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
InaajiriHatua 1/2
- Nkarta Investigational Site, New York
A Study of AZD0120 in Autoimmune Diseases
InaajiriHatua 1
- Research Site, New York
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
InaajiriHatua 1
- Montefiore Medical Center, New York
Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis
InaajiriHatua 2
- Hospital for Special Surgery, New York
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
InaajiriHatua 2
- aTyr Investigative Site, New York
Majaribio ya Scleroderma katika miji mingine
- Ann Arbor, MIUtafiti 10
- Chicago, ILUtafiti 10
- Houston, TXUtafiti 9
- Boston, MAUtafiti 7
- Durham, NCUtafiti 7
- Los Angeles, CAUtafiti 7
- New Orleans, LAUtafiti 6
- Baltimore, MDUtafiti 6
- Philadelphia, PAUtafiti 6
- Dallas, TXUtafiti 5
- Pittsburgh, PAUtafiti 5
- Plantation, FLUtafiti 4
Masomo mengine katika New York City
- Saratani ya MatitiUtafiti 134
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 120
- Saratani (aina zote)Utafiti 110
- Saratani ya ProstateUtafiti 103
- Saratani ya MetastasiUtafiti 93
- Kansari ya kolorektaliUtafiti 77
- Kansari ya MayaiUtafiti 69
- Saratan ya MapafuUtafiti 60
- Kansari ya PancreasUtafiti 60
- Multiple MyelomaUtafiti 60
- Saratani ya EndometrialUtafiti 52
- Kushindwa kwa MoyoUtafiti 51
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.